KalVista Pharmaceuticals (KALV) EBITDA Margin (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly EBITDA Margin of 107.49% in Q3 2025, up 78.59% quarter-over-quarter from 502.11% in Q2 2025.
KalVista Pharmaceuticals' EBITDA Margin history runs 8 years deep, the most recent figure standing at 107.49% for Q3 2025.
- In Q3 2025, EBITDA Margin changed N/A year-over-year to 107.49%; the TTM figure through Jul 2025 stood at 276.27% (up 124448.0% YoY), while the FY2025 annual figure was 1683.36%, down 142922.0% from the prior year.
- EBITDA Margin came in at 107.49% for Q3 2025 at KalVista Pharmaceuticals, up from 502.11% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 107.49% in Q3 2025 to a low of 502.11% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -107.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -107.49% |
| Apr 30, 2025 | -502.11% |
| Apr 30, 2020 | -185.25% |
| Jan 31, 2020 | -583.96% |
| Oct 31, 2019 | -137.24% |
| Jul 31, 2019 | -219.62% |
| Apr 30, 2019 | -285.41% |
| Jan 31, 2019 | -98.23% |
| Oct 31, 2018 | -55.63% |
| Jul 31, 2018 | -170.79% |
| Apr 30, 2018 | -33.68% |
| Jan 31, 2018 | -120.12% |
| Oct 31, 2017 | -446.23% |
| Jul 31, 2017 | -5,012.50% |
| Apr 30, 2017 | -3,454.39% |
| Jan 31, 2017 | -3,015.32% |
| Oct 31, 2016 | -1,000.00% |
| Jul 31, 2016 | 90.77% |
| Mar 31, 2016 | -93,257.14% |
| Dec 31, 2015 | -79,557.14% |
| Sep 30, 2015 | -69,985.71% |
| Jun 30, 2015 | -80,957.14% |
| Mar 31, 2015 | -70,014.29% |
| Sep 30, 2014 | -35,680.00% |
| Jun 30, 2014 | -48,720.00% |
| Mar 31, 2014 | -30,933.33% |